Skip to main content

Table 2 Comparison of descriptive characteristics of symptomatic and asymptomatic WNV+ subjects

From: Enhancement of Zika virus infection by antibodies from West Nile virus seropositive individuals with no history of clinical infection

 

Symptomatic WNV+ subjects

Asymptomatic WNV+ subjects

 

No. (n = 19a)

%

No.(n = 28)

%

p-value

Gender

Male

11

57.9%

19

67.9%

0.5462

Female

8

42.1%

9

32.1%

Age (years)

< 50

3

15.8%

15

53.6%

0.0140

≥50

16

84.2%

13

46.4%

Race

Hispanic

10

52.6%

26

92.9%

ND

White

8

42.1%

2

7.1%

Black

0

0.0%

0

0.0%

Asian

0

0.0%

0

0.0%

Otherb

1

5.3%

0

0.0%

  1. a20 patients were referred from the public health department with a previous history of WNV diagnosis
  2. bOther: includes mixed races and those who chose not to respond
  3. p-value was determined using the Fisher exact test. ND-Not determined
  4. However, only 19 tested positive in WNV E IgG ELISA